Skip to main content
REAX
NASDAQ Real Estate & Construction

Real REMAX Group's First Combined 10-Q: $727.9M Revenue, $67.2M Net Loss, $525M Term Loan

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Real Estate Services Stocks · Real Estate
Sentiment info
Neutral
Importance info
7
Price
$16.31
Mkt Cap
$621.214M
52W Low
$13.25
52W High
$45
52W Position info
23% above low
Off High info
64% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

REAX sits 23% above its 52-week low of $13.25.

Summary

Real REMAX Group's first combined quarter produced $727.9M of revenue and $33.8M of Adjusted EBITDA, but $52.3M of deal costs pushed GAAP to a $67.2M net loss. The new $525.0M term loan carries a 9.4% rate and a leverage covenant first tested December 31, 2026.


Key Events · Earnings and Guidance · REAX

  • First Combined Quarter Reported

    Q3 2026 revenue of $727.9M, up 28% from $568.5M, including about five weeks of REMAX operations from the August 24, 2026 closing.

  • Deal Costs Drive GAAP Loss

    Net loss of $67.2M, or $2.25 per diluted share, after $52.3M of acquisition and integration expenses and $26.4M of accelerated stock-based compensation; Adjusted EBITDA was $33.8M.

  • Leverage and Covenant Test Ahead

    $525.0M of principal term loans outstanding at a 9.4% rate, with a first-lien net leverage covenant of 4.50:1.00 first tested December 31, 2026; the $40.0M revolver is undrawn.

  • Provisional Purchase Accounting

    $907.8M of total consideration allocated to $327.9M of goodwill, $300.0M of franchise agreements and $205.0M of trademarks, all still subject to change within the one-year measurement period.


Analysis · REAX · Real Estate & Construction

This is the first full set of financial statements for the merged Real/REMAX company, and it shows what the combination actually looks like: revenue of $727.9M in the quarter (up 28%) and $33.8M of Adjusted EBITDA, but a $67.2M GAAP net loss driven by $52.3M of acquisition and integration costs plus $26.4M of accelerated stock compensation. The balance sheet is now levered — $525.0M of principal term loans at a 9.4% rate, roughly $5.9M of quarterly interest expense, and a first-lien leverage covenant of 4.50:1.00 that gets tested for the first time on December 31, 2026. Cash of $102.5M plus a fully undrawn $40.0M revolver covers near-term needs, and the company already prepaid $25.0M of the term loan on September 30. The purchase accounting is provisional: $327.9M of goodwill and $505.0M of intangibles can still move within the one-year measurement period, and REMAX is excluded from the 2026 internal-control assessment while integration is underway.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, REAX was trading at $16.31 on NASDAQ in the Real Estate & Construction sector, with a market capitalization of approximately $621.2M. The 52-week trading range was $13.25 to $45.00. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

REAX - Latest Insights

REAX
Nov 05, 2026, 2:20 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $15.37
Real-time Price: $10.79 info
Change: -$4.58 (-30%) info
Market Cap: $405.913M info
REAX
Nov 05, 2026, 7:15 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $16.31
Real-time Price: $10.79 info
Change: -$5.52 (-34%) info
Market Cap: $405.913M info
REAX
Nov 05, 2026, 7:00 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $15.80
Real-time Price: $10.79 info
Change: -$5.01 (-32%) info
Market Cap: $405.913M info
REAX
Nov 03, 2026, 4:05 PM EST
Filing Type: 8-K12B/A
Importance Score:
7
Price at Filing: $15.23
Real-time Price: $10.79 info
Change: -$4.44 (-29%) info
Market Cap: $405.913M info
REAX
Aug 24, 2026, 4:47 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $2.65
Real-time Price: $10.79 info
Change: Reverse Stock Split info
Market Cap: $405.913M info